• SIGN IN
  • GET HELP
  •  

    Webinar Details


    Event Type

    Live Online

    Date

    Friday, October 11, 2019

    Time

    10:30 AM - 11:45 AM ET

    Location

    PharmCon Webinar Studio (freeCE.com)

    Credits

    1.25 Contact Hour(s)

    Target Audience

    Pharmacist, Pharmacy Technician, Nurse

    Cost

    $30.00

    • Overview

      The guideline governing the management of blood cholesterol to reduce cardiovascular risk was recently revised at the end of 2018. Several critical changes were made to the guideline, including the identification of high risk and very high-risk factors, restructuring of patient groups in which to consider drug therapy, revised therapeutic targets, and incorporation of newer non-statin drugs to the clinical armamentarium. It is imperative to disseminate these updates to healthcare practitioners, so that they can provide evidence-based, patient-centered care as members of an interdisciplinary team. 


      Handouts

      Slide Document 19083L01_6pp.pdf
      Slide Document 19083L01_2pp.pdf





      Financial Support By

      PharmCon
    • Pharmacist

      Recognize the relationship between dyslipidemia and atherosclerotic cardiovascular disease (ASCVD), including risk assessment
      Identify key recommendations from the 2018 Guideline on the Management of Blood Cholesterol
      Recognize the role of pharmacotherapy in dysplipidemia management to optimize pharmacotherapy plans and outcomes for patients with dyslipidemia

      Pharmacy Technician

      Recognize the relationship between dyslipidemia and atherosclerotic cardiovascular disease (ASCVD)
      Recognize the role of pharmacotherapy in dyslipidemia management

      Nurse

      Recognize the relationship between dyslipidemia and atherosclerotic cardiovascular disease (ASCVD), including risk assessment
      Identify key recommendations from the 2018 Guideline on the Management of Blood Cholesterol
      Recognize the role of pharmacotherapy in dysplipidemia management to optimize pharmacotherapy plans and outcomes for patients with dyslipidemia
    • Repeat Presentation

      This presentation was last given on 10/11/2019 10:30 AM

      Future Airings

      There are no future airings of this activity scheduled at this time.

    • Activity Type

      Knowledge

      CE Broker

      20-721450

      Universal Activity Number

      Pharmacist 0798-0000-19-083-L01-P

      Pharmacy Technician 0798-0000-19-083-L01-T

      Nurse 0798-0000-19-083-L01-N

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, attendees must answer poll questions and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.


    HARDWARE REQUIREMENTS
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
     


    SOFTWARE REQUIREMENTS
    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Safari
    Firefox 3.0.3 or higher


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).




    Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.